Ablative Solutions Inc.
- Address
- 301 Edgewater Place Suite 100
Sponsor Overview
Specializations
Cardiovascular Interventional Therapeutics
Ablative Solutions Inc. concentrates its research efforts on innovative interventional approaches for managing cardiovascular conditions. The company's investigational work centers on catheter-based ablation technologies designed to address critical hemodynamic disorders. Their therapeutic development targets conditions where sympathetic nervous system modulation may offer clinical benefit, particularly in patients with persistent cardiovascular abnormalities resistant to conventional pharmacological management.
- Renal Denervation Procedures
- Hypertension Management
- Minimally Invasive Vascular Interventions
The sponsor's research platform explores the therapeutic potential of targeted nerve ablation within the cardiovascular system, investigating outcomes related to blood pressure regulation and long-term cardiovascular risk reduction. This work represents a focus on device-based interventions that complement or potentially reduce reliance on traditional antihypertensive medications in selected patient populations.
Autonomic Nervous System Modulation
The organization pursues research into therapeutic interventions that modify autonomic nervous system activity as a mechanism for treating chronic disease states. Their investigational approach examines how selective interruption of sympathetic nerve pathways can influence systemic physiological processes, particularly those contributing to cardiovascular pathology. This research direction represents an alternative therapeutic paradigm that addresses disease mechanisms rather than solely managing symptoms.
- Sympathetic Nerve Activity Reduction
- Neurogenic Cardiovascular Dysfunction
- Autonomic Balance Restoration
The clinical investigations supported by Ablative Solutions Inc. examine both immediate procedural outcomes and sustained physiological effects of neuromodulation therapies, with particular attention to safety profiles and durability of therapeutic responses in patients with treatment-resistant conditions.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Renal Denervation via Ethanol-Mediated Neurolysis Using the Peregrine System™ Kit in Patients with Uncontrolled Hypertension |  Austria Belgium France Germany Ireland Poland The Netherlands | Not Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.
This sponsor has worked with 32 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
Partnered Research Centres
32 centres- Address
- Ul. Franklina Delano Roosevelta 2, 47-200 Kedzierzyn-Kozle
- Address
- Eissendorfer Pferdeweg 52, Heimfeld, 21075 Hamburg
- Address
- 264 Rue Saint Pierre, 13005 Marseille
- Address
- Senator-Wessling-Strasse 1a, Kattenturm, 28277 Bremen
- Address
- Frankfurt Seckbacher Landstr. 65, 60389 Frankfurt
- Address
- 4 Boulevard Hauterive, Cs 17595, 64046 Pau
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Ablative Solutions Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.